In conclusion, this study reveals the significant role of bifidobacteria and its metabolite lactic acid in improving NAFLD, particularly through the inhibition of the NLRP3 inflammasome and modulation of autophagy to alleviate liver inflammation and lipid metabolism disorders. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.